Loading story…
(RTTNews) - Serina Therapeutics, Inc. (SER), a clinical-stage biotechnology company, reported that the NYSE American LLC has accepted the company's business plan to regain compliance with the continued listing…
(RTTNews) - Serina Therapeutics, Inc. (SER), a clinical-stage biotechnology company, reported that the NYSE American LLC has accepted the company's business plan to regain compliance with the continued listing standards of NYSE. Serina will now have until July 9, 2027, to regain
Same desk, different stories
A Big Undeveloped Silver Project Won’t Produce an Ounce Before 2034
S&P 500 Breakout Sets the Tone for Cautious Market Recovery
Iran Changed Everything – Can Global Equity Sustain 2025 Strength?
Absci: Compelling AI Biotech Story, but Weak Fundamentals and Bearish Structure
Oil Shock Sets Up Inflation Test as Markets Eye CPI, PCE Data This Week
(RTTNews) - JFE Holdings, Inc. (JFEEF5411.T), and Mitsubishi Corp. (8058.T, MSBHF), said they have signed a second memorandum of understanding.